Other downstream gene products of NF-κB activation including MCP-1, CX3CL1 and IL-6 have also been reported to be overexpressed in endothelial cells of PAH patients by immunohistochemistry [47]–[49]. This evidence concerns the gene CCL2 and pulmonary arterial hypertension.